Cargando…
SEOM clinical guideline on unknown primary cancer (2017)
Cancer of unknown primary site is a histologically confirmed cancer that manifests in advanced stage, with no identifiable primary site following standard diagnostic procedures. Patients are initially categorized based on the findings of the initial biopsy: adenocarcinoma, squamous-cell carcinoma, n...
Autores principales: | Losa, F., Soler, G., Casado, A., Estival, A., Fernández, I., Giménez, S., Longo, F., Pazo-Cid, R., Salgado, J., Seguí, M. Á. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5785607/ https://www.ncbi.nlm.nih.gov/pubmed/29230692 http://dx.doi.org/10.1007/s12094-017-1807-y |
Ejemplares similares
-
SEOM—GECOD clinical guideline for unknown primary cancer (2021)
por: Losa, Ferrán, et al.
Publicado: (2022) -
Clinical guideline SEOM: cancer of unknown primary site
por: Collado Martín, R., et al.
Publicado: (2014) -
Clinical guideline SEOM: hepatocellular carcinoma
por: Sastre, J., et al.
Publicado: (2015) -
SEOM clinical guidelines in gestational trophoblastic disease (2017)
por: Santaballa, A., et al.
Publicado: (2017) -
SEOM clinical guidelines for pancreatic and biliary tract cancer (2020)
por: Gómez-España, Mª A., et al.
Publicado: (2021)